Janux Therapeutics (JANX) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Janux Therapeutics (JANX) over the last 5 years, with Q3 2025 value amounting to 0.01.
- Janux Therapeutics' Asset Utilization Ratio fell 4834.75% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 4834.75%. This contributed to the annual value of 0.01 for FY2024, which is 3237.37% down from last year.
- Latest data reveals that Janux Therapeutics reported Asset Utilization Ratio of 0.01 as of Q3 2025, which was down 4834.75% from 0.0 recorded in Q2 2025.
- Janux Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.03 during Q1 2023, with a 5-year trough of 0.0 in Q2 2025.
- For the 5-year period, Janux Therapeutics' Asset Utilization Ratio averaged around 0.02, with its median value being 0.02 (2022).
- In the last 5 years, Janux Therapeutics' Asset Utilization Ratio surged by 27817.06% in 2022 and then tumbled by 9807.68% in 2025.
- Over the past 5 years, Janux Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then soared by 146.76% to 0.02 in 2022, then fell by 9.51% to 0.02 in 2023, then tumbled by 42.78% to 0.01 in 2024, then dropped by 19.35% to 0.01 in 2025.
- Its Asset Utilization Ratio stands at 0.01 for Q3 2025, versus 0.0 for Q2 2025 and 0.01 for Q1 2025.